Telmisartan

In the US, Telmisartan (telmisartan systemic) is a member of the drug class angiotensin II inhibitors and is used to treat Cardiovascular Risk Reduction, High Blood Pressure and Prevention of Cardiovascular Disease.

US matches:

• Telmisartan


• Telmisartan/Amlodipine


• Telmisartan and amlodipine


• Telmisartan and hydrochlorothiazide


• Telmisartan/Hydrochlorothiazide

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

C09CA07

CAS registry number (Chemical Abstracts Service)

0144701-48-4

Chemical Formula

C33-H30-N4-O2

Molecular Weight

514

Therapeutic Categories

Antihypertensive agent

Angiotensin-II antagonist

Chemical Name

[1,1'-Biphenyl]-2-carboxylic acid, 4'-[(1,4'-dimethyl-2'-propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-

Foreign Names

• Telmisartanum (Latin)
• Telmisartan (German)
• Telmisartan (French)
• Telmisartan (Spanish)

Generic Names

• Telmisartan (OS: USAN, DCF, BAN)
• BIBR 277 SE (IS: Boehringer Ingelheim)
• Telmisartan (PH: Ph. Eur. 6, BP 2010)
• Telmisartanum (PH: Ph. Eur. 6)

Brand Names

• Co-Micardis (Telmisartan and Hydrochlorothiazide)
  Boehringer Ingelheim, South Africa



• Deprevex
  Klonal, Argentina



• Domidis
  Domesco, Vietnam



• Gliosartan
  Bagó, Argentina



• Kinzal
  Bayer, Switzerland



• Kinzalkomb (Telmisartan and Hydrochlorothiazide)
  Bayer, Belgium; Bayer, Germany; Bayer, Netherlands; Bayer, Slovakia; Bayer AG, Luxembourg



• Kinzalmono
  Bayer, Belgium; Bayer, Germany; Bayer, Finland; Bayer, Netherlands; Bayer AG, Luxembourg



• Kinzalplus (Telmisartan and Hydrochlorothiazide)
  Bayer, Switzerland



• Micardis HCT (Telmisartan and Hydrochlorothiazide)
  Boehringer Ingelheim, United States



• Micardis Plus (Telmisartan and Hydrochlorothiazide)
  Boehringer Ingelheim, Belgium; Boehringer Ingelheim, China; Boehringer Ingelheim, Spain; Boehringer Ingelheim, United Kingdom; Boehringer Ingelheim, Greece; Boehringer Ingelheim, Singapore; Boehringer Ingelheim, Slovenia



• Micardis
  Abbott, United States; Boehringer Ingelheim, United Arab Emirates; Boehringer Ingelheim, Argentina; Boehringer Ingelheim, Australia; Boehringer Ingelheim, Belgium; Boehringer Ingelheim, Bahrain; Boehringer Ingelheim, Brazil; Boehringer Ingelheim, Canada; Boehringer Ingelheim, Switzerland; Boehringer Ingelheim, Chile; Boehringer Ingelheim, China; Boehringer Ingelheim, Colombia; Boehringer Ingelheim, Costa Rica; Boehringer Ingelheim, Cyprus; Boehringer Ingelheim, Czech Republic; Boehringer Ingelheim, Germany; Boehringer Ingelheim, Denmark; Boehringer Ingelheim, Dominican Republic; Boehringer Ingelheim, Egypt; Boehringer Ingelheim, Spain; Boehringer Ingelheim, Finland; Boehringer Ingelheim, France; Boehringer Ingelheim, United Kingdom; Boehringer Ingelheim, Greece; Boehringer Ingelheim, Guatemala; Boehringer Ingelheim, Hong Kong; Boehringer Ingelheim, Honduras; Boehringer Ingelheim, Croatia (Hrvatska); Boehringer Ingelheim, Hungary; Boehringer Ingelheim, Indonesia; Boehringer Ingelheim, Ireland; Boehringer Ingelheim, Iraq; Boehringer Ingelheim, Italy; Boehringer Ingelheim, Jordan; Boehringer Ingelheim, Japan; Boehringer Ingelheim, Kenya; Boehringer Ingelheim, Kuwait; Boehringer Ingelheim, Lebanon; Boehringer Ingelheim, Libya; Boehringer Ingelheim, Mexico; Boehringer Ingelheim, Malaysia; Boehringer Ingelheim, Nicaragua; Boehringer Ingelheim, Netherlands; Boehringer Ingelheim, Norway; Boehringer Ingelheim, Oman; Boehringer Ingelheim, Panama; Boehringer Ingelheim, Peru; Boehringer Ingelheim, Poland; Boehringer Ingelheim, Portugal; Boehringer Ingelheim, Qatar; Boehringer Ingelheim, Romania; Boehringer Ingelheim, Serbia; Boehringer Ingelheim, Russian Federation; Boehringer Ingelheim, Saudi Arabia; Boehringer Ingelheim, Sudan; Boehringer Ingelheim, Sweden; Boehringer Ingelheim, Singapore; Boehringer Ingelheim, Slovenia; Boehringer Ingelheim, Slovakia; Boehringer Ingelheim, El Salvador; Boehringer Ingelheim, Thailand; Boehringer Ingelheim, Turkey; Boehringer Ingelheim, Taiwan; Boehringer Ingelheim, United States; Boehringer Ingelheim, Venezuela; Boehringer Ingelheim, Vietnam; Boehringer Ingelheim, Yemen; Boehringer Ingelheim, South Africa; Boehringer Ingelheim International, Austria; Boehringer Ingelheim International, Luxembourg



• MicardisPlus (Telmisartan and Hydrochlorothiazide)
  Boehringer Ingelheim, Canada; Boehringer Ingelheim, Switzerland; Boehringer Ingelheim, Germany; Boehringer Ingelheim, Denmark; Boehringer Ingelheim, France; Boehringer Ingelheim, Croatia (Hrvatska); Boehringer Ingelheim, Hungary; Boehringer Ingelheim, Indonesia; Boehringer Ingelheim, Ireland; Boehringer Ingelheim, Netherlands; Boehringer Ingelheim, Norway; Boehringer Ingelheim, Sweden; Boehringer Ingelheim, Slovakia; Boehringer Ingelheim, Thailand; Boehringer Ingelheim, Vietnam; Boehringer Ingelheim International, Austria



• Mitosan
  Novartis, Bangladesh



• Predxal
  Armstrong, Mexico



• Pritor Plus (Telmisartan and Hydrochlorothiazide)
  Bayer, Spain; Bayer, Croatia (Hrvatska); Bayer, Slovakia



• Pritor
  Bayer, Spain; Bayer, Croatia (Hrvatska); Bayer, Hungary; Bayer, Italy; Bayer, Slovakia; Bayer AG, Luxembourg; Bayer Schering, France; Glaxo Wellcome, Portugal; GlaxoSmithKline, Bosnia & Herzegowina; GlaxoSmithKline, Brazil; GlaxoSmithKline, Czech Republic; GlaxoSmithKline, Greece; GlaxoSmithKline, Peru; GlaxoSmithKline, Philippines; GlaxoSmithKline, Romania; GlaxoSmithKline, Slovenia; GlaxoSmithKline, Turkey; GlaxoSmithKline, Venezuela



• Pritorplus (Telmisartan and Hydrochlorothiazide)
  Bayer, Denmark; Bayer, Hungary; Bayer, Italy; Bayer, Slovenia; Bayer Schering, France



• Saitan
  WPU, China



• Samertan
  Bago, Chile



• Telma
  Glenmark, India; Glenmark, Vietnam



• Telpres
  Nicholas, India



• Telsan
  Orion, Bangladesh



• Twynsta (Telmisartan and Amlodipine)
  Boehringer Ingelheim, United States

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
IS	Inofficial Synonym
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.